CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- Open-market buys, last 90 days
- $1,001,990
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,001,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Strobeck Matthew Director | Grant or award · Restricted Stock Units | +6,804 | 6,804 | ||
| 2026-01-02 | Strobeck Matthew Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2025-05-20 | Strobeck Matthew Director | Grant or award · Restricted Stock Units | +80,525 | 80,525 | ||
| 2025-05-20 | Strobeck Matthew Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2024-11-05 | Strobeck Matthew Director | Purchase | +4,000 | $1.40 | $6K | 89,673 |
| 2024-11-05 | Strobeck Matthew Director | Purchase | +36,000 | $1.40 | $50K | 2,606,879 |
| 2024-05-23 | Strobeck Matthew Director | Exercise or conversion | +52,160 | 85,673 | ||
| 2024-05-23 | Strobeck Matthew Director | Exercise or conversion | +295,680 | 2,570,879 | ||
| 2024-05-23 | Strobeck Matthew Director | Exercise or conversion · Series A Non-Voting Convertible Preferred Stock | −1,304 | 0 | ||
| 2024-05-23 | Strobeck Matthew Director | Exercise or conversion · Series A Non-Voting Convertible Preferred Stock | −7,392 | 0 | ||
| 2024-05-21 | Strobeck Matthew Director | Grant or award · Restricted Stock Units | +53,726 | 53,726 | ||
| 2024-05-21 | Strobeck Matthew Director | Grant or award · Stock Options (Right to Buy) | +37,050 | 37,050 | ||
| 2024-04-05 | Strobeck Matthew Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +1,304 | $46.00 | $60K | 1,304 |
| 2024-04-05 | Strobeck Matthew Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +7,392 | $46.00 | $340K | 7,392 |
| 2024-01-01 | Strobeck Matthew Director | Grant or award · Restricted Stock Units | +105,389 | 140,036 | ||
| 2023-08-03 | Strobeck Matthew Director | Grant or award | +127,777 | $1.62 | $207K | 2,542,928 |
| 2023-08-03 | Strobeck Matthew Director | Grant or award | +6,790 | $1.62 | $11K | 119,003 |
| 2023-08-03 | Strobeck Matthew Director | Grant or award | +6,790 | $1.62 | $11K | 119,003 |
| 2023-08-03 | Strobeck Matthew Director | Grant or award | +6,790 | $1.62 | $11K | 119,003 |
| 2023-08-03 | Strobeck Matthew Director | Grant or award | +6,790 | $1.62 | $11K | 119,003 |
Page 1 of 2 · 39 trades